Tidutamab (Anti-CD3 & SSTR2)Tidutamab (Anti-CD3 & SSTR2)
Move your mouse over image or click to enlarge

Tidutamab (Anti-CD3 & SSTR2)

Tidutamab (Anti-CD3 & SSTR2) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). It can be used in neuroendocrine tumors (NETs) and small cell lung cancer (SCLC). MW :147.36 KD.
Cat# Size Price Qty Buy
A3170-1mg*25 1mg*25
£4,152.00
A3170-1mg*5 1mg*5
£1,384.00
A3170-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3170

Related Documents